nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfasalazine—SLC7A11—Riluzole—amyotrophic lateral sclerosis	0.615	0.884	CbGbCtD
Sulfasalazine—PTGS2—amyotrophic lateral sclerosis	0.165	1	CbGaD
Sulfasalazine—ABCG2—Riluzole—amyotrophic lateral sclerosis	0.0807	0.116	CbGbCtD
Sulfasalazine—TBXAS1—forelimb—amyotrophic lateral sclerosis	0.00687	0.119	CbGeAlD
Sulfasalazine—TBXAS1—hindlimb—amyotrophic lateral sclerosis	0.00618	0.107	CbGeAlD
Sulfasalazine—TBXAS1—appendage—amyotrophic lateral sclerosis	0.0053	0.0921	CbGeAlD
Sulfasalazine—SLC7A11—tongue—amyotrophic lateral sclerosis	0.00269	0.0468	CbGeAlD
Sulfasalazine—PPARG—forelimb—amyotrophic lateral sclerosis	0.00259	0.045	CbGeAlD
Sulfasalazine—PPARG—hindlimb—amyotrophic lateral sclerosis	0.00233	0.0405	CbGeAlD
Sulfasalazine—PPARG—appendage—amyotrophic lateral sclerosis	0.002	0.0347	CbGeAlD
Sulfasalazine—ACAT1—medulla oblongata—amyotrophic lateral sclerosis	0.00135	0.0234	CbGeAlD
Sulfasalazine—ACAT1—spinal cord—amyotrophic lateral sclerosis	0.0012	0.0209	CbGeAlD
Sulfasalazine—PTGS2—hindlimb—amyotrophic lateral sclerosis	0.00119	0.0207	CbGeAlD
Sulfasalazine—IKBKB—embryo—amyotrophic lateral sclerosis	0.00107	0.0185	CbGeAlD
Sulfasalazine—PTGS2—appendage—amyotrophic lateral sclerosis	0.00102	0.0178	CbGeAlD
Sulfasalazine—ACAT1—nervous system—amyotrophic lateral sclerosis	0.00101	0.0176	CbGeAlD
Sulfasalazine—ACAT1—central nervous system—amyotrophic lateral sclerosis	0.000973	0.0169	CbGeAlD
Sulfasalazine—ACAT1—cerebellum—amyotrophic lateral sclerosis	0.000951	0.0165	CbGeAlD
Sulfasalazine—SLC46A1—spinal cord—amyotrophic lateral sclerosis	0.000894	0.0155	CbGeAlD
Sulfasalazine—TBXAS1—nervous system—amyotrophic lateral sclerosis	0.000845	0.0147	CbGeAlD
Sulfasalazine—TBXAS1—central nervous system—amyotrophic lateral sclerosis	0.000813	0.0141	CbGeAlD
Sulfasalazine—ACAT1—brain—amyotrophic lateral sclerosis	0.000773	0.0134	CbGeAlD
Sulfasalazine—SLC46A1—nervous system—amyotrophic lateral sclerosis	0.000753	0.0131	CbGeAlD
Sulfasalazine—SLC7A11—spinal cord—amyotrophic lateral sclerosis	0.000736	0.0128	CbGeAlD
Sulfasalazine—SLC46A1—central nervous system—amyotrophic lateral sclerosis	0.000725	0.0126	CbGeAlD
Sulfasalazine—SLC46A1—cerebellum—amyotrophic lateral sclerosis	0.000709	0.0123	CbGeAlD
Sulfasalazine—CHUK—cerebellum—amyotrophic lateral sclerosis	0.000709	0.0123	CbGeAlD
Sulfasalazine—PLA2G1B—nervous system—amyotrophic lateral sclerosis	0.000708	0.0123	CbGeAlD
Sulfasalazine—PLA2G1B—central nervous system—amyotrophic lateral sclerosis	0.000682	0.0119	CbGeAlD
Sulfasalazine—PPARG—embryo—amyotrophic lateral sclerosis	0.000663	0.0115	CbGeAlD
Sulfasalazine—TBXAS1—brain—amyotrophic lateral sclerosis	0.000646	0.0112	CbGeAlD
Sulfasalazine—SLC7A11—nervous system—amyotrophic lateral sclerosis	0.00062	0.0108	CbGeAlD
Sulfasalazine—SLC7A11—central nervous system—amyotrophic lateral sclerosis	0.000597	0.0104	CbGeAlD
Sulfasalazine—SLC7A11—cerebellum—amyotrophic lateral sclerosis	0.000584	0.0101	CbGeAlD
Sulfasalazine—SLC46A1—brain—amyotrophic lateral sclerosis	0.000576	0.01	CbGeAlD
Sulfasalazine—CHUK—brain—amyotrophic lateral sclerosis	0.000576	0.01	CbGeAlD
Sulfasalazine—PLA2G1B—brain—amyotrophic lateral sclerosis	0.000541	0.00941	CbGeAlD
Sulfasalazine—IKBKB—nervous system—amyotrophic lateral sclerosis	0.000512	0.0089	CbGeAlD
Sulfasalazine—IKBKB—central nervous system—amyotrophic lateral sclerosis	0.000493	0.00857	CbGeAlD
Sulfasalazine—IKBKB—cerebellum—amyotrophic lateral sclerosis	0.000482	0.00838	CbGeAlD
Sulfasalazine—SLC7A11—brain—amyotrophic lateral sclerosis	0.000474	0.00824	CbGeAlD
Sulfasalazine—ALOX5—nervous system—amyotrophic lateral sclerosis	0.000424	0.00738	CbGeAlD
Sulfasalazine—Balsalazide—PTGS2—amyotrophic lateral sclerosis	0.000412	0.54	CrCbGaD
Sulfasalazine—ALOX5—central nervous system—amyotrophic lateral sclerosis	0.000408	0.0071	CbGeAlD
Sulfasalazine—ALOX5—cerebellum—amyotrophic lateral sclerosis	0.000399	0.00694	CbGeAlD
Sulfasalazine—IKBKB—brain—amyotrophic lateral sclerosis	0.000391	0.0068	CbGeAlD
Sulfasalazine—Olsalazine—PTGS2—amyotrophic lateral sclerosis	0.000351	0.459	CrCbGaD
Sulfasalazine—PTGS2—embryo—amyotrophic lateral sclerosis	0.000339	0.00589	CbGeAlD
Sulfasalazine—ALOX5—brain—amyotrophic lateral sclerosis	0.000324	0.00564	CbGeAlD
Sulfasalazine—PPARG—nervous system—amyotrophic lateral sclerosis	0.000319	0.00554	CbGeAlD
Sulfasalazine—PPARG—central nervous system—amyotrophic lateral sclerosis	0.000307	0.00533	CbGeAlD
Sulfasalazine—ABCG2—medulla oblongata—amyotrophic lateral sclerosis	0.000272	0.00472	CbGeAlD
Sulfasalazine—PPARG—brain—amyotrophic lateral sclerosis	0.000243	0.00423	CbGeAlD
Sulfasalazine—ABCG2—spinal cord—amyotrophic lateral sclerosis	0.000242	0.00421	CbGeAlD
Sulfasalazine—PTGS2—medulla oblongata—amyotrophic lateral sclerosis	0.000217	0.00377	CbGeAlD
Sulfasalazine—PTGS1—spinal cord—amyotrophic lateral sclerosis	0.000202	0.00351	CbGeAlD
Sulfasalazine—PTGS2—spinal cord—amyotrophic lateral sclerosis	0.000193	0.00336	CbGeAlD
Sulfasalazine—ABCG2—cerebellum—amyotrophic lateral sclerosis	0.000192	0.00334	CbGeAlD
Sulfasalazine—PTGS1—nervous system—amyotrophic lateral sclerosis	0.00017	0.00296	CbGeAlD
Sulfasalazine—PTGS1—central nervous system—amyotrophic lateral sclerosis	0.000164	0.00285	CbGeAlD
Sulfasalazine—PTGS2—nervous system—amyotrophic lateral sclerosis	0.000163	0.00283	CbGeAlD
Sulfasalazine—PTGS2—central nervous system—amyotrophic lateral sclerosis	0.000157	0.00272	CbGeAlD
Sulfasalazine—ABCG2—brain—amyotrophic lateral sclerosis	0.000156	0.00271	CbGeAlD
Sulfasalazine—PTGS2—cerebellum—amyotrophic lateral sclerosis	0.000153	0.00266	CbGeAlD
Sulfasalazine—PTGS1—brain—amyotrophic lateral sclerosis	0.00013	0.00226	CbGeAlD
Sulfasalazine—PTGS2—brain—amyotrophic lateral sclerosis	0.000124	0.00216	CbGeAlD
Sulfasalazine—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—amyotrophic lateral sclerosis	4.32e-05	0.000531	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—FIG4—amyotrophic lateral sclerosis	4.32e-05	0.000531	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—ERBB4—amyotrophic lateral sclerosis	4.31e-05	0.00053	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—TPK1—amyotrophic lateral sclerosis	4.25e-05	0.000523	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—VAPB—amyotrophic lateral sclerosis	4.25e-05	0.000523	CbGpPWpGaD
Sulfasalazine—CHUK—p75(NTR)-mediated signaling—TP53—amyotrophic lateral sclerosis	4.24e-05	0.000521	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	4.12e-05	0.000506	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	4.11e-05	0.000505	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	4.02e-05	0.000494	CbGpPWpGaD
Sulfasalazine—ABCC2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	4.02e-05	0.000494	CbGpPWpGaD
Sulfasalazine—ABCC2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	4.02e-05	0.000494	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.97e-05	0.000488	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—TPK1—amyotrophic lateral sclerosis	3.94e-05	0.000484	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—VAPB—amyotrophic lateral sclerosis	3.94e-05	0.000484	CbGpPWpGaD
Sulfasalazine—IKBKB—Rac1/Pak1/p38/MMP-2 pathway—TP53—amyotrophic lateral sclerosis	3.93e-05	0.000484	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—DAO—amyotrophic lateral sclerosis	3.91e-05	0.00048	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—ERBB4—amyotrophic lateral sclerosis	3.91e-05	0.00048	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.89e-05	0.000479	CbGpPWpGaD
Sulfasalazine—IKBKB—p75(NTR)-mediated signaling—TP53—amyotrophic lateral sclerosis	3.84e-05	0.000473	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—ERBB4—amyotrophic lateral sclerosis	3.84e-05	0.000473	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	3.8e-05	0.000468	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—VAPB—amyotrophic lateral sclerosis	3.78e-05	0.000465	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—TPK1—amyotrophic lateral sclerosis	3.78e-05	0.000465	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.77e-05	0.000464	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.77e-05	0.000464	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.77e-05	0.000463	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—APOE—amyotrophic lateral sclerosis	3.76e-05	0.000462	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—IGF1—amyotrophic lateral sclerosis	3.74e-05	0.00046	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	3.7e-05	0.000455	CbGpPWpGaD
Sulfasalazine—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	3.68e-05	0.000453	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CHMP2B—amyotrophic lateral sclerosis	3.67e-05	0.000451	CbGpPWpGaD
Sulfasalazine—CHUK—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	3.67e-05	0.000451	CbGpPWpGaD
Sulfasalazine—PPARG—Gene Expression—RARA—amyotrophic lateral sclerosis	3.65e-05	0.000449	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	3.63e-05	0.000447	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—CHAT—amyotrophic lateral sclerosis	3.62e-05	0.000446	CbGpPWpGaD
Sulfasalazine—CHUK—Apoptosis—TP53—amyotrophic lateral sclerosis	3.62e-05	0.000445	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.62e-05	0.000445	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—VAPA—amyotrophic lateral sclerosis	3.6e-05	0.000443	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—TPK1—amyotrophic lateral sclerosis	3.59e-05	0.000441	CbGpPWpGaD
Sulfasalazine—ABCC2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.58e-05	0.00044	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	3.53e-05	0.000434	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.53e-05	0.000434	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by SCF-KIT—MMP9—amyotrophic lateral sclerosis	3.53e-05	0.000434	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	3.49e-05	0.00043	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	3.49e-05	0.00043	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	3.47e-05	0.000427	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.46e-05	0.000426	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.46e-05	0.000426	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.4e-05	0.000418	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.36e-05	0.000413	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.35e-05	0.000412	CbGpPWpGaD
Sulfasalazine—IKBKB—BDNF signaling pathway—CASP3—amyotrophic lateral sclerosis	3.33e-05	0.000409	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PLB1—amyotrophic lateral sclerosis	3.32e-05	0.000408	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	3.31e-05	0.000408	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	3.31e-05	0.000407	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	3.29e-05	0.000405	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis—TP53—amyotrophic lateral sclerosis	3.28e-05	0.000404	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.22e-05	0.000396	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	3.2e-05	0.000393	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	3.15e-05	0.000388	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—FIG4—amyotrophic lateral sclerosis	3.15e-05	0.000387	CbGpPWpGaD
Sulfasalazine—ABCG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	3.11e-05	0.000383	CbGpPWpGaD
Sulfasalazine—IKBKB—Apoptosis Modulation and Signaling—TP53—amyotrophic lateral sclerosis	3.08e-05	0.000379	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—DAO—amyotrophic lateral sclerosis	3.08e-05	0.000378	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	3.03e-05	0.000372	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—FIG4—amyotrophic lateral sclerosis	3.03e-05	0.000372	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—ATF1—amyotrophic lateral sclerosis	3.01e-05	0.000371	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—VAPB—amyotrophic lateral sclerosis	3e-05	0.00037	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—TPK1—amyotrophic lateral sclerosis	3e-05	0.00037	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	3e-05	0.000369	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—APOE—amyotrophic lateral sclerosis	2.97e-05	0.000366	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PLB1—amyotrophic lateral sclerosis	2.96e-05	0.000364	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—VCP—amyotrophic lateral sclerosis	2.96e-05	0.000364	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—CASP3—amyotrophic lateral sclerosis	2.94e-05	0.000362	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—DCTN1—amyotrophic lateral sclerosis	2.93e-05	0.00036	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	2.93e-05	0.00036	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—CASP9—amyotrophic lateral sclerosis	2.87e-05	0.000353	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—VTA1—amyotrophic lateral sclerosis	2.87e-05	0.000353	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—DAO—amyotrophic lateral sclerosis	2.85e-05	0.00035	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—APOE—amyotrophic lateral sclerosis	2.85e-05	0.00035	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	2.82e-05	0.000347	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	2.82e-05	0.000347	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	2.8e-05	0.000345	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	2.76e-05	0.000339	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—VAPA—amyotrophic lateral sclerosis	2.75e-05	0.000338	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.75e-05	0.000338	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—DAO—amyotrophic lateral sclerosis	2.74e-05	0.000337	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—ATF1—amyotrophic lateral sclerosis	2.73e-05	0.000336	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—GSR—amyotrophic lateral sclerosis	2.73e-05	0.000336	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—DCTN1—amyotrophic lateral sclerosis	2.66e-05	0.000327	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—CASP9—amyotrophic lateral sclerosis	2.6e-05	0.00032	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	2.58e-05	0.000317	CbGpPWpGaD
Sulfasalazine—ACAT1—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.57e-05	0.000317	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.55e-05	0.000314	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—CASP3—amyotrophic lateral sclerosis	2.55e-05	0.000313	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	2.53e-05	0.000311	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CASP9—amyotrophic lateral sclerosis	2.5e-05	0.000307	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—APOE—amyotrophic lateral sclerosis	2.49e-05	0.000306	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	2.49e-05	0.000306	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	2.48e-05	0.000305	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	2.46e-05	0.000302	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—VEGFA—amyotrophic lateral sclerosis	2.44e-05	0.0003	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—MMP9—amyotrophic lateral sclerosis	2.41e-05	0.000296	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—FIG4—amyotrophic lateral sclerosis	2.4e-05	0.000295	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.4e-05	0.000295	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	2.36e-05	0.00029	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.33e-05	0.000287	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.32e-05	0.000286	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	2.27e-05	0.000279	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	2.26e-05	0.000279	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	2.26e-05	0.000278	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.25e-05	0.000277	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—CHAT—amyotrophic lateral sclerosis	2.24e-05	0.000276	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—ERBB4—amyotrophic lateral sclerosis	2.23e-05	0.000274	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	2.22e-05	0.000273	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	2.18e-05	0.000269	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CHMP2B—amyotrophic lateral sclerosis	2.17e-05	0.000267	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—DAO—amyotrophic lateral sclerosis	2.17e-05	0.000267	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PLB1—amyotrophic lateral sclerosis	2.16e-05	0.000265	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GSR—amyotrophic lateral sclerosis	2.15e-05	0.000265	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—ERBB4—amyotrophic lateral sclerosis	2.14e-05	0.000263	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CST3—amyotrophic lateral sclerosis	2.12e-05	0.000261	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	2.12e-05	0.000261	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	2.11e-05	0.000259	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—APOE—amyotrophic lateral sclerosis	2.08e-05	0.000256	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PLB1—amyotrophic lateral sclerosis	2.07e-05	0.000255	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—VCP—amyotrophic lateral sclerosis	2.07e-05	0.000255	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	2.05e-05	0.000252	CbGpPWpGaD
Sulfasalazine—CHUK—Innate Immune System—C3—amyotrophic lateral sclerosis	2.04e-05	0.000251	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	2.04e-05	0.000251	CbGpPWpGaD
Sulfasalazine—SLC46A1—Disease—PTGS2—amyotrophic lateral sclerosis	2.04e-05	0.00025	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—CD40LG—amyotrophic lateral sclerosis	2.01e-05	0.000247	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	2.01e-05	0.000247	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GSR—amyotrophic lateral sclerosis	1.99e-05	0.000245	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	1.98e-05	0.000244	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—PLB1—amyotrophic lateral sclerosis	1.97e-05	0.000242	CbGpPWpGaD
Sulfasalazine—CHUK—Adaptive Immune System—C3—amyotrophic lateral sclerosis	1.96e-05	0.000241	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.96e-05	0.000241	CbGpPWpGaD
Sulfasalazine—TBXAS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.95e-05	0.00024	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.95e-05	0.00024	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling by NGF—CASP3—amyotrophic lateral sclerosis	1.92e-05	0.000236	CbGpPWpGaD
Sulfasalazine—PPARG—Circadian rythm related genes—TP53—amyotrophic lateral sclerosis	1.92e-05	0.000236	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GSR—amyotrophic lateral sclerosis	1.91e-05	0.000235	CbGpPWpGaD
Sulfasalazine—IKBKB—MAPK Signaling Pathway—TP53—amyotrophic lateral sclerosis	1.89e-05	0.000232	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—VCP—amyotrophic lateral sclerosis	1.88e-05	0.000231	CbGpPWpGaD
Sulfasalazine—CHUK—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.88e-05	0.000231	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—SQSTM1—amyotrophic lateral sclerosis	1.87e-05	0.00023	CbGpPWpGaD
Sulfasalazine—IKBKB—Innate Immune System—C3—amyotrophic lateral sclerosis	1.85e-05	0.000228	CbGpPWpGaD
Sulfasalazine—SLC7A11—Hemostasis—TP53—amyotrophic lateral sclerosis	1.85e-05	0.000227	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	1.82e-05	0.000224	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.79e-05	0.00022	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.78e-05	0.000219	CbGpPWpGaD
Sulfasalazine—IKBKB—Adaptive Immune System—C3—amyotrophic lateral sclerosis	1.78e-05	0.000219	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.77e-05	0.000217	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.76e-05	0.000217	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ATF1—amyotrophic lateral sclerosis	1.76e-05	0.000216	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—VCP—amyotrophic lateral sclerosis	1.75e-05	0.000215	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.74e-05	0.000214	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.73e-05	0.000213	CbGpPWpGaD
Sulfasalazine—SLC46A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.71e-05	0.00021	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—SQSTM1—amyotrophic lateral sclerosis	1.7e-05	0.000209	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CASP9—amyotrophic lateral sclerosis	1.67e-05	0.000206	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PLB1—amyotrophic lateral sclerosis	1.65e-05	0.000202	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.64e-05	0.000201	CbGpPWpGaD
Sulfasalazine—PTGS2—Spinal Cord Injury—TP53—amyotrophic lateral sclerosis	1.63e-05	0.000201	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	1.61e-05	0.000199	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.61e-05	0.000198	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	1.6e-05	0.000196	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ATF1—amyotrophic lateral sclerosis	1.59e-05	0.000196	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.57e-05	0.000193	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	1.55e-05	0.00019	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—CASP9—amyotrophic lateral sclerosis	1.54e-05	0.00019	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GSR—amyotrophic lateral sclerosis	1.52e-05	0.000187	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CASP9—amyotrophic lateral sclerosis	1.52e-05	0.000186	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—APOE—amyotrophic lateral sclerosis	1.47e-05	0.000181	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.47e-05	0.000181	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.43e-05	0.000176	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—ERBB4—amyotrophic lateral sclerosis	1.43e-05	0.000176	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	1.43e-05	0.000176	CbGpPWpGaD
Sulfasalazine—PLA2G1B—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.42e-05	0.000175	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.4e-05	0.000173	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.38e-05	0.00017	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—MMP9—amyotrophic lateral sclerosis	1.38e-05	0.000169	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—CD40LG—amyotrophic lateral sclerosis	1.35e-05	0.000165	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—ERBB4—amyotrophic lateral sclerosis	1.32e-05	0.000162	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—ERBB4—amyotrophic lateral sclerosis	1.3e-05	0.00016	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CST3—amyotrophic lateral sclerosis	1.26e-05	0.000155	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—CHAT—amyotrophic lateral sclerosis	1.25e-05	0.000153	CbGpPWpGaD
Sulfasalazine—PPARG—Developmental Biology—VEGFA—amyotrophic lateral sclerosis	1.24e-05	0.000152	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—CD40LG—amyotrophic lateral sclerosis	1.22e-05	0.00015	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.21e-05	0.000149	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.21e-05	0.000148	CbGpPWpGaD
Sulfasalazine—CHUK—Immune System—C3—amyotrophic lateral sclerosis	1.19e-05	0.000146	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	1.17e-05	0.000144	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.14e-05	0.00014	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.13e-05	0.00014	CbGpPWpGaD
Sulfasalazine—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.11e-05	0.000137	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.11e-05	0.000136	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	1.1e-05	0.000136	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	1.1e-05	0.000135	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	1.08e-05	0.000133	CbGpPWpGaD
Sulfasalazine—IKBKB—Immune System—C3—amyotrophic lateral sclerosis	1.08e-05	0.000133	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	1.03e-05	0.000127	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—APOE—amyotrophic lateral sclerosis	1.02e-05	0.000126	CbGpPWpGaD
Sulfasalazine—ALOX5—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.01e-05	0.000124	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	9.82e-06	0.000121	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	9.8e-06	0.000121	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—GSTP1—amyotrophic lateral sclerosis	9.49e-06	0.000117	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	9.25e-06	0.000114	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—CASP9—amyotrophic lateral sclerosis	9.14e-06	0.000112	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—APOE—amyotrophic lateral sclerosis	9.12e-06	0.000112	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.79e-06	0.000108	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.72e-06	0.000107	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	8.7e-06	0.000107	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—GSTP1—amyotrophic lateral sclerosis	8.45e-06	0.000104	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	8.39e-06	0.000103	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	8.08e-06	9.94e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	7.89e-06	9.7e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—ERBB4—amyotrophic lateral sclerosis	7.82e-06	9.62e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	7.76e-06	9.55e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—C3—amyotrophic lateral sclerosis	7.69e-06	9.45e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—APOE—amyotrophic lateral sclerosis	7.18e-06	8.83e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—APOE—amyotrophic lateral sclerosis	7.16e-06	8.8e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Disease—PTGS2—amyotrophic lateral sclerosis	7e-06	8.61e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—C3—amyotrophic lateral sclerosis	6.97e-06	8.57e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.7e-06	8.25e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—APOE—amyotrophic lateral sclerosis	6.65e-06	8.18e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—APOE—amyotrophic lateral sclerosis	6.49e-06	7.98e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—APOE—amyotrophic lateral sclerosis	6.39e-06	7.85e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.3e-06	7.75e-05	CbGpPWpGaD
Sulfasalazine—PPARG—Metabolism—PTGS2—amyotrophic lateral sclerosis	6.25e-06	7.68e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.16e-06	7.58e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Disease—APOE—amyotrophic lateral sclerosis	6.05e-06	7.45e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.91e-06	7.27e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	5.79e-06	7.12e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	5.36e-06	6.59e-05	CbGpPWpGaD
Sulfasalazine—PTGS2—Metabolism—APOE—amyotrophic lateral sclerosis	5.07e-06	6.24e-05	CbGpPWpGaD
Sulfasalazine—SLCO1B1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.92e-06	6.05e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	4.76e-06	5.86e-05	CbGpPWpGaD
Sulfasalazine—ABCG2—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.55e-06	5.6e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.55e-06	5.6e-05	CbGpPWpGaD
Sulfasalazine—PTGS1—Metabolism—PTGS2—amyotrophic lateral sclerosis	4.38e-06	5.38e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	4.3e-06	5.29e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	4.13e-06	5.08e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	3.9e-06	4.8e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.86e-06	4.75e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	3.5e-06	4.31e-05	CbGpPWpGaD
Sulfasalazine—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.26e-06	4.01e-05	CbGpPWpGaD
Sulfasalazine—CHUK—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.92e-06	3.59e-05	CbGpPWpGaD
Sulfasalazine—IKBKB—Signaling Pathways—TP53—amyotrophic lateral sclerosis	2.65e-06	3.25e-05	CbGpPWpGaD
